Clinical Trials Directory

Trials / Terminated

TerminatedNCT03364686

Transfusion of Biotin-Labeled Red Blood Cells

Transfusion of Biotin-Labeled Red Blood Cells for the Evaluation of Genetic Factors That Contribute to Donor Differences in Red Blood Cell Storage and Post-Transfusion Red Blood Cell Recovery

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Gladwin, Mark, MD · Individual
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to evaluate the impact of genetic and biologic factors in blood donors on red blood cell storage stability after autologous transfusion over the different range of storage period of 5-7 days and 35-42 days in healthy volunteers.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiotin-Labeled Red Blood CellsWe will collect 500 mL of blood. The blood will be processed and split into two bags and labeled with a naturally occurring vitamin, biotin. The blood will then be re-infused back into the same participant at 2 time points (5-7 days and 35-42 days after storage).

Timeline

Start date
2019-09-16
Primary completion
2021-03-02
Completion
2021-06-29
First posted
2017-12-06
Last updated
2022-04-21
Results posted
2022-04-21

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03364686. Inclusion in this directory is not an endorsement.